Related Experiment Video
Updated: Aug 16, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
The maillard reaction in eye diseases
1Ophthalmic Research Centre, Queen's University Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland. a.stitt@qub.ac.uk
Abstract:
Diabetes and age-related eye disorders remain leading causes of blindness worldwide. While defined pathogenic mechanisms for many of these diseases remain elusive, there is increasing evidence that products of the Maillard reaction may play an important role in their etiology. Advanced glycation end products (AGEs) form though a range of pathways within Maillard chemistry, and there is evidence to suggest that these adducts accumulate in the intracellular and/or extracellular environment of ocular structures. This review evaluates the ever-growing literature on AGEs in biological systems and draws relevant links to diseases such as diabetic retinopathy, age-related macular degeneration, and cataract formation. It also outlines recent pharmaceutical strategies to inhibit Maillard reaction products and provides links to how these may serve to limit ocular cell dysfunction.
Insights
Advanced glycation end products (AGEs), formed via Maillard reactions, are increasingly linked to eye diseases like diabetic retinopathy and cataracts. Research explores inhibiting these products to prevent ocular cell dysfunction and blindness.
Area of Science:
- Ophthalmology
- Biochemistry
- Pathology
Background:
- Diabetes and aging are primary risk factors for global blindness.
- The exact causes of many age-related eye diseases are not fully understood.
- Maillard reaction products, specifically advanced glycation end products (AGEs), are implicated in disease development.
Purpose of the Study:
- To review the literature on advanced glycation end products (AGEs) in biological systems.
- To establish the connection between AGEs and ocular diseases.
- To discuss therapeutic strategies targeting AGE formation for ocular health.
Main Methods:
- Comprehensive literature review of studies on AGEs and eye disorders.
- Analysis of evidence linking AGE accumulation in ocular structures to disease pathogenesis.
- Evaluation of current pharmaceutical approaches to inhibit AGE formation.
Main Results:
- AGEs accumulate in ocular tissues, contributing to conditions like diabetic retinopathy, age-related macular degeneration, and cataracts.
- The Maillard reaction is a significant pathway in the etiology of these vision-impairing diseases.
- Emerging pharmaceutical strategies show promise in inhibiting AGEs.
Conclusions:
- Advanced glycation end products (AGEs) are critical factors in the development of major eye diseases.
- Inhibiting AGE formation represents a potential therapeutic avenue to preserve ocular function and prevent blindness.
- Further research into AGE pathways and inhibitors is warranted for effective treatment strategies.
Related Concept Videos
Diabetic Retinopathy
Photoreceptors and Visual Pathways
Glaucoma: Overview

